Tokyo, Japan

Kazuma Obara

This inventor holds 2 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Canon Kabushiki Kaisha. Active years: 2022-2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazuma Obara: Innovator in Radiographing Technology

Introduction

Kazuma Obara is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of radiography, particularly through his innovative patent that enhances imaging technology. His work is instrumental in improving the accuracy and efficiency of radiographic procedures.

Latest Patents

Kazuma Obara holds a patent for a radiographing apparatus, radiographing system, and dose index management method. This invention includes a selecting unit that allows users to select a target dose index for radiographing based on the imaging mode. Additionally, it features a dose index acquiring unit that retrieves a dose index from image data based on radiation transmitted through a subject. The calculating unit calculates a deviation index of the dose index concerning the target dose index. Furthermore, the apparatus may include a display control unit that presents information regarding the imaging mode, target dose index, and dose index on a display unit. He has 1 patent to his name.

Career Highlights

Kazuma Obara is associated with Canon Kabushiki Kaisha, a leading company in imaging and optical products. His role at Canon has allowed him to contribute to advancements in radiographic technology, showcasing his expertise and innovative spirit.

Conclusion

Kazuma Obara's work in radiographing technology exemplifies the impact of innovation in medical imaging. His contributions continue to influence the field, enhancing the quality of radiographic practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…